Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Fiorini, Ada ^a,b   Sultana, Rukhsana ^b   Barone, Eugenio ^a,c   Cenini, Giovanna ^b   Perluigi, Marzia ^a   Mancuso, Cesare ^c   Cai, Jian ^d   Klein, Jon B ^d   St Clair, Daret ^b   Butterfield, D Allan ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF KENTUCKY   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 5; ASPARTATE AMINOTRANSFERASE; FUMARATE HYDRATASE; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 1; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HEAT SHOCK COGNATE PROTEIN 70; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; PEROXIREDOXIN 3; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; ENZYME ACTIVITY; ENZYME REGULATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEOMICS;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; PROTEOMICS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84870267018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049846     Document Type: Article

References (69)

1. Vousden KH, Lu X, (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
2. Vousden KH, (2006) Outcomes of p53 activation-spoilt for choice. J Cell Sci 119: 5015-5020.
3. Horn HF, Vousden KH, (2007) Coping with stress: multiple ways to activate p53. Oncogene 26: 1306-1316.
4. Oren M, (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442.
5. Greenblatt MS, Bennett WP, Hollstein M, Harris CC, (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878.
6. Lim YP, Lim TT, Chan YL, Song ACM, Yeo BH, et al. (2006) The p53 knowledgebase: an integrated information resource for p53 research. Oncogene 26: 1517-1521.
7. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, et al. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
8. Butterfield DA, Poon HF, St. Clair D, Keller JN, Pierce WM, et al. (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiology of Disease 22: 223-232.
9. Butterfield DA, Reed T, Newman SF, Sultana R, (2007) Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology and Medicine 43: 658-677.
10. Momand J, Wu H-H, Dasgupta G, (2000) MDM2 - master regulator of the p53 tumor suppressor protein. Gene 242: 15-29.
11. Liu B, Chen Y, St. Clair DK, (2008) ROS and p53: A versatile partnership. Free Radical Biology and Medicine 44: 1529-1535.
12. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B, (1997) A model for p53-induced apoptosis. Nature 389: 300-305.
13. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T, (1996) Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 93: 11848-11852.
14. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, et al. (2005) The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313.
15. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu S-S, (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. American Journal of Physiology - Cell Physiology 287: C817-C833.
16. Raha S, Robinson BH, (2000) Mitochondria, oxygen free radicals, disease and ageing. Trends in Biochemical Sciences 25: 502-508.
17. Pani G, Bedogni B, Anzevino R, Colavitti R, Palazzotti B, et al. (2000) Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res 60: 4654-4660.
18. Holley AK, Dhar SK, St. Clair DK, (2010) Manganese superoxide dismutase versus p53: the mitochondrial center. Annals of the New York Academy of Sciences 1201: 72-78.
19. Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, et al. (2012) Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One 7: e29789.
20. Barone E, Cenini G, Sultana R, Di Domenico F, Fiorini A, et al. (2012) Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxid Redox Signal 16: 1407-1420.
21. Holley AK, St. Clair DK, (2009) Watching the watcher: regulation of p53 by mitochondria. Future Oncol 5: 117-130.
22. Sims NR, (1990) Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J Neurochem 55: 698-707.
23. Sultana R, Perluigi M, Butterfield DA (2012) Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer's disease brain. Free Radic Biol Med, in press.
24. Sionov RV, Haupt Y, (1999) The cellular response to p53: the decision between life and death. Oncogene 18: 6145-6157.
25. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, et al. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev 18: 306-319.
26. Cenini G, Sultana R, Memo M, Butterfield DA, (2008) Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE,in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease. Journal of Cellular and Molecular Medicine 12: 987-994.
27. Cenini G, Sultana R, Memo M, Butterfield DA, (2008) Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radical Biology and Medicine 45: 81-85.
28. Di Domenico F, Cenini G, Sultana R, Perluigi M, Uberti D, et al. (2009) Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochem Res 34: 727-733.
29. Martindale JL, Holbrook NJ, (2002) Cellular response to oxidative stress: Signaling for suicide and survival*. Journal of Cellular Physiology 192: 1-15.
30. Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL, et al. (1999) MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proceedings of the National Academy of Sciences 96: 15127-15132.
31. Butterfield DA, Drake J, Pocernich C, Castegna A, (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends in Molecular Medicine 7: 548-554.
32. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, et al. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. Journal of Neurochemistry 85: 1394-1401.
33. Markesbery WR, (1997) Oxidative Stress Hypothesis in Alzheimer's Disease. Free Radical Biology and Medicine 23: 134-147.
34. Drane P, Bravard A, Bouvard V, May E, (2001) Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis. Oncogene 20: 430-439.
35. Dhar SK, Xu Y, Chen Y, St Clair DK, (2006) Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 281: 21698-21709.
36. Sompol P, Ittarat W, Tangpong J, Chen Y, Doubinskaia I, et al. (2008) A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience 153: 120-130.
37. Rhee SG, Kang SW, Netto LE, Seo MS, Stadtman ER, (1999) A family of novel peroxidases, peroxiredoxins. Biofactors 10: 207-209.
38. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM, (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304: 596-600.
39. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, et al. (2002) Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031.
40. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, et al. (1999) PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18: 127-137.
41. Nonn L, Berggren M, Powis G, (2003) Increased Expression of Mitochondrial Peroxiredoxin-3 (Thioredoxin Peroxidase-2) Protects Cancer Cells Against Hypoxia and Drug-Induced Hydrogen Peroxide-Dependent Apoptosis11CA52995 and CA772049. Molecular Cancer Research 1: 682-689.
42. Chen L, Na R, Gu M, Salmon AB, Liu Y, et al. (2008) Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 7: 866-878.
43. Kim SH, Fountoulakis M, Cairns N, Lubec G (2001) Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl: 223-235.
44. Macellaro A, Tujulin E, Hjalmarsson K, Norlander L, (1998) Identification of a 71-kilodalton surface-associated Hsp70 homologue in Coxiella burnetii. Infect Immun 66: 5882-5888.
45. Agoff SN, Hou J, Linzer DI, Wu B, (1993) Regulation of the human hsp70 promoter by p53. Science 259: 84-87.
46. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, et al. (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20: 7146-7159.
47. Kouchi Z, Sorimachi H, Suzuki K, Ishiura S, (1999) Proteasome Inhibitors Induce the Association of Alzheimer's Amyloid Precursor Protein with Hsc73. Biochemical and Biophysical Research Communications 254: 804-810.
48. Dworniczak B, Mirault ME, (1987) Structure and expression of a human gene coding for a 71 kd heat shock 'cognate' protein. Nucleic Acids Res 15: 5181-5197.
49. Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G, (2001) Deranged Expression of Molecular Chaperones in Brains of Patients with Alzheimer's Disease. Biochemical and Biophysical Research Communications 280: 249-258.
50. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, et al. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82: 1524-1532.
51. Holley AK, St Clair DK, (2009) Watching the watcher: regulation of p53 by mitochondria. Future Oncology 5: 117-130.
52. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS, (2006) The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr Pharm Des 12: 2249-2270.
53. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ, (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517.
54. Ferecatu I, Bergeaud M, Rodríguez-Enfedaque A, Le Floch N, Oliver L, et al. (2009) Mitochondrial localization of the low level p53 protein in proliferative cells. Biochemical and Biophysical Research Communications 387: 772-777.
55. Olovnikov IA, Kravchenko JE, Chumakov PM, (2009) Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense. Seminars in Cancer Biology 19: 32-41.
56. Perluigi M, Di Domenico F, Giorgi A, Schininà ME, Coccia R, et al. (2010) Redox proteomics in aging rat brain: Involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. Journal of Neuroscience Research 88: 3498-3507.
57. Schägger H, Ohm TG, (1995) Human Diseases with Defects in Oxidative Phosphorylation. European Journal of Biochemistry 227: 916-921.
58. Reddy PH, (2009) Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectr 14: 8-13.
59. Puzio-Kuter AM, (2011) The Role of p53 in Metabolic Regulation. Genes Cancer 2: 385-391.
60. Maddocks OD, Vousden KH, (2011) Metabolic regulation by p53. J Mol Med (Berl) 89: 237-245.
61. Boyd-Kimball D, Castegna A, Sultana R, Poon HF, Petroze R, et al. (2005) Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: Implications for Alzheimer's disease. Brain Research 1044: 206-215.
62. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce Jr WM, et al. (2006) Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer's disease. Neurobiology of Aging 27: 1239-1249.
63. Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, et al. (2005) Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice. Molecular & Cellular Proteomics 4: 1849-1861.
64. Lindahl R, (1992) Aldehyde dehydrogenases and their role in carcinogenesis. Crit rev Biochem Mol Biol 27: 283-335.
65. Murphy TC, Amarnath V, Gibson KM, Picklo Sr MJ, (2003) Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). Journal of Neurochemistry 86: 298-305.
66. Murphy TC, Amarnath V, Picklo Sr MJ, (2003) Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex. Journal of Neurochemistry 84: 1313-1321.
67. Butterfield DA, Bader Lange ML, Sultana R, (2010) Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801: 924-929.
68. Yoon K-A, Nakamura Y, Arakawa H, (2004) Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140.
69. Papazoglu C, Mills AA, (2007) p53: at the crossroad between cancer and ageing. The Journal of Pathology 211: 124-133.